Navigating Your Semaglutide Journey: Understanding Units and Personalized Dosing

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Starting semaglutide therapy can feel overwhelming when you're learning about units, dose progression, and whether a particular strength will work for your body. Clinical studies show that response to GLP-1 medications varies significantly based on individual genetics, metabolic factors, and baseline weight—meaning the right dose for one person may differ completely from another. PlexusDx simplifies this journey by combining compounded semaglutide therapy with precision genetic insights to match you with your optimal treatment path.

How Semaglutide Units Work and Why They Matter

Semaglutide is measured in milligrams (mg), not units—a critical distinction that prevents dosing confusion. A standard semaglutide pen or vial contains a specific concentration of the medication dissolved in solution, and your prescribed dose reflects the exact amount of active drug you'll inject. Unlike insulin, which uses international units, semaglutide therapy relies on weight-based dosing adjusted for tolerability and clinical response. Understanding this measurement system helps you track your progress and communicate clearly with your healthcare provider.

PlexusDx compounded semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan), with your dose potentially increasing as your body adjusts to treatment. Your dose may need to go up—your price won't. This pricing model removes the financial barrier to reaching your therapeutic dose, whether that's 0.5 mg, 1.0 mg, 2.0 mg, or higher. Many patients worry that advancing to a stronger dose means paying significantly more, but PlexusDx's flat-rate structure ensures you're never penalized for needing additional medication as your treatment progresses.

The Role of Genetics in Semaglutide Response and Personalization

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predispositions means you're not guessing whether semaglutide alone will work or whether you might benefit from a combination therapy like GLP-Squared (semaglutide plus tirzepatide). Patients with certain genetic variants may respond exceptionally well to microdose GLP-1 protocols, while others achieve better results with standard or higher concentrations. This personalized approach eliminates months of trial-and-error adjustments and accelerates your path to sustainable weight loss results.

Building Your Dose: What to Expect During Your First Months

Most semaglutide protocols begin with a low starting dose and gradually increase every week or every two weeks to minimize nausea and gastrointestinal side effects. A typical progression might begin at 0.25 mg, increase to 0.5 mg, then advance through 1.0 mg and 1.5 mg over 8–12 weeks until you reach your target maintenance dose. This titration schedule allows your body to build tolerance to appetite suppression and metabolic changes while your provider monitors your weight loss, side effect profile, and metabolic markers. Throughout this process, your PlexusDx monthly price remains unchanged, removing cost anxiety from dose advancement.

Real-world data shows that patients who complete a full titration schedule experience more sustainable weight loss and better medication tolerance than those who jump to higher doses quickly. Your individualized semaglutide journey depends on your starting weight, metabolic health, prior weight loss medication experience, and genetic factors revealed by precision testing. PlexusDx healthcare providers use this combination of clinical data and genetic insights to recommend the progression schedule most likely to deliver results while keeping you comfortable and compliant.

Beyond Semaglutide: When to Consider Dual-Peptide Therapy

Some patients reach a weight loss plateau on semaglutide monotherapy, especially those with genetic variants affecting GIPR signaling (rs1800437) or MC4R function (rs17782313). PlexusDx offers GLP-Squared Injection—a dual-compound formula combining semaglutide and tirzepatide—at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients who need additional metabolic support. Tirzepatide activates both GLP-1 and GIP receptors, creating a broader appetite and energy regulation signal than semaglutide alone. Clinical trials demonstrate that dual-peptide therapy produces greater weight loss than either medication individually in patients with specific genetic profiles.

Your Precision Peptide Genetic Test results guide this decision by identifying whether your genetics suggest strong GIP pathway activation potential or whether you might benefit from intensified GLP-1 signaling. If dual therapy becomes appropriate, PlexusDx's flat-rate pricing means upgrading from semaglutide to GLP-Squared Injection costs only $100 more per month—a transparent, predictable investment in your next phase of treatment. Oral options (semaglutide at $289/mo or tirzepatide at $349/mo) are also available for patients preferring tablets over injections.

Accessing PlexusDx Semaglutide: No Insurance, No Memberships, No Barriers

PlexusDx compounds semaglutide and all GLP-1 medications through licensed 503A compounding pharmacies—facilities regulated by the U.S. Pharmacopeia (USP) and state pharmacy boards—ensuring pharmaceutical-grade quality without requiring FDA approval of the individual compounded product. You don't need insurance coverage, a membership fee, or prior authorization to start therapy; PlexusDx serves all 50 states and accepts HSA and FSA funds for both medications and the Precision Peptide Genetic Test. This accessibility means cost is never a reason to delay starting your personalized weight loss journey.

Your first month of compounded semaglutide injection is $189/mo month-to-month, or from $149/mo on the 6-month plan, with the option to add genetic testing ($298) after you've completed your first dose to inform dose optimization and future medication choices. If you prefer oral semaglutide, that option is $289/mo month-to-month (or $249/mo on the 6-month plan). Across all three commitment tiers, your price remains flat regardless of dose level, reflecting PlexusDx's core principle: your dose may need to go up, your price won't. Contact PlexusDx to confirm coverage details and set up your initial telemedicine consultation with a licensed provider.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test is $298. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What dose of semaglutide should I start with if I'm new to GLP-1 therapy?

Most patients start with 0.25 mg weekly and increase gradually at intervals set by your prescriber, commonly about every 4 weeks based on tolerance and response. Your PlexusDx provider will recommend a personalized titration schedule after reviewing your medical history and, if available, your Precision Peptide Genetic Test results. Starting low minimizes nausea while allowing your body to adapt.

How much weight loss can I expect from semaglutide, and does it vary by dose?

Clinical trials show weight loss ranging from 5–15% of body weight over 6 months on semaglutide monotherapy, with higher doses generally producing greater results in responders.

Why does PlexusDx charge a flat monthly price instead of varying by dose?

PlexusDx's flat-rate model removes financial barriers to dose advancement. Your dose may need to go up as your body adjusts—your price won't. This pricing structure ensures you can reach your therapeutic dose without worrying about escalating costs, at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection across all three tiers.

Are compounded semaglutide medications safe, and how are they regulated?

Yes—PlexusDx sources all medications from licensed 503A compounding pharmacies regulated by the USP and state pharmacy boards. These facilities follow strict quality and sterility standards.

How does the Precision Peptide Genetic Test improve my semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide Dosing
• Medvi Semaglutide
• Bioverse Semaglutide
• Ro Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.